Literature DB >> 20609273

Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients.

Ralph H B Benedict1, Sarah A Morrow, Bianca Weinstock Guttman, Diane Cookfair, David J Schretlen.   

Abstract

Cognitive reserve is widely recognized as a moderator of cognitive decline in patients with senile dementias such as Alzheimer's disease. The same effect may occur in multiple sclerosis (MS), an immunologic disorder affecting the central nervous system. While MS is traditionally considered an inflammatory, white matter disease, degeneration of gray matter is increasingly recognized as the primary contributor to progressive cognitive decline. Our aim was to determine if individual differences in estimated cognitive reserve protect against the progression of cognitive dysfunction in MS. Ninety-one patients assessed twice roughly 5 years apart were identified retrospectively. Cognitive testing emphasized mental processing speed. Cognitive reserve was estimated by years of education and by performance on the North American Adult Reading Test (NAART). After controlling for baseline characteristics, both years of education (p = .013) and NAART scores (p = .049) significantly improved regression models predicting cognitive decline. Symbol Digit Modalities Test (SDMT) performance showed no significant change in patients with > 14 years of education, whereas it declined significantly in patients with ≤ 14 years of education. We conclude that greater cognitive reserve as indexed by either higher premorbid intelligence or more years of education protects against the progression of cognitive dysfunction in MS.

Entities:  

Mesh:

Year:  2010        PMID: 20609273     DOI: 10.1017/S1355617710000688

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  41 in total

1.  Cognitive profiles in heart failure: a cluster analytic approach.

Authors:  Lindsay A Miller; Mary Beth Spitznagel; Michael L Alosco; Ronald A Cohen; Naftali Raz; Lawrence H Sweet; Lisa Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Clin Exp Neuropsychol       Date:  2012-03-01       Impact factor: 2.475

2.  Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).

Authors:  Francesco Patti; Maria Pia Amato; Maria Trojano; Stefano Bastianello; Maria Rosalia Tola; Orietta Picconi; Sabina Cilia; Salvatore Cottone; Luigi M E Grimaldi
Journal:  Qual Life Res       Date:  2011-09-28       Impact factor: 4.147

3.  Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.

Authors:  Tomas Uher; Jana Blahova-Dusankova; Dana Horakova; Niels Bergsland; Michaela Tyblova; Ralph H B Benedict; Tomas Kalincik; Deepa P Ramasamy; Zdenek Seidl; Jesper Hagermeier; Manuela Vaneckova; Jan Krasensky; Eva Havrdova; Robert Zivadinov
Journal:  J Neurol       Date:  2014-06-22       Impact factor: 4.849

4.  A new perspective on proxy report: Investigating implicit processes of understanding through patient-proxy congruence.

Authors:  Carolyn E Schwartz; Armon Ayandeh; Jonathan D Rodgers; Paul Duberstein; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  Qual Life Res       Date:  2015-06-03       Impact factor: 4.147

5.  Cognitive slowing and its underlying neurobiology in temporal lobe epilepsy.

Authors:  Gyujoon Hwang; Kevin Dabbs; Lisa Conant; Veena A Nair; Jed Mathis; Dace N Almane; Andrew Nencka; Rasmus Birn; Colin Humphries; Manoj Raghavan; Edgar A DeYoe; Aaron F Struck; Rama Maganti; Jeffrey R Binder; Elizabeth Meyerand; Vivek Prabhakaran; Bruce Hermann
Journal:  Cortex       Date:  2019-03-05       Impact factor: 4.027

6.  Speech and pause characteristics in multiple sclerosis: a preliminary study of speakers with high and low neuropsychological test performance.

Authors:  Lynda Feenaughty; Kris Tjaden; Ralph H B Benedict; Bianca Weinstock-Guttman
Journal:  Clin Linguist Phon       Date:  2013-02       Impact factor: 1.346

7.  Cognitive reserve moderates the association between heart failure and cognitive impairment.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Manfred van Dulmen; Lisa H Colbert; Richard Josephson; Donna Waechter; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Clin Exp Neuropsychol       Date:  2011-10-31       Impact factor: 2.475

8.  A simple measure of cognitive reserve is relevant for cognitive performance in MS patients.

Authors:  Marida Della Corte; Gabriella Santangelo; Alvino Bisecco; Rosaria Sacco; Mattia Siciliano; Alessandro d'Ambrosio; Renato Docimo; Teresa Cuomo; Luigi Lavorgna; Simona Bonavita; Gioacchino Tedeschi; Antonio Gallo
Journal:  Neurol Sci       Date:  2018-05-04       Impact factor: 3.307

9.  Cognitive reserve and brain reserve in prodromal Huntington's disease.

Authors:  Aaron Bonner-Jackson; Jeffrey D Long; Holly Westervelt; Geoffrey Tremont; Elizabeth Aylward; Jane S Paulsen
Journal:  J Int Neuropsychol Soc       Date:  2013-05-23       Impact factor: 2.892

10.  Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.

Authors:  James F Sumowski; Maria A Rocca; Victoria M Leavitt; Jelena Dackovic; Sarlota Mesaros; Jelena Drulovic; John DeLuca; Massimo Filippi
Journal:  Neurology       Date:  2014-04-18       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.